Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs
Go back to Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs| Mitsubishi Chemical Holdings Corp Unsponsored ADR (AMEX: MTLHY) | Delayed: 34.97 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.97 | 52 Week High | $34.07 | |||
| Open | $34.97 | 52 Week Low | $21.84 | |||
| Day High | $34.97 | P/E | N/A | |||
| Day Low | $34.97 | EPS | $0.00 | |||
| Volume | 130 | |||||
| Regeneron (NASDAQ: REGN) | Delayed: 790.74 -5.6 (0.7%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $796.34 | 52 Week High | $592.36 | |||
| Open | $803.01 | 52 Week Low | $325.35 | |||
| Day High | $805.68 | P/E | 207.54 | |||
| Day Low | $787.32 | EPS | $3.81 | |||
| Volume | 653,987 | |||||
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 41.50 +0.39 (0.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.11 | 52 Week High | $66.55 | |||
| Open | $41.26 | 52 Week Low | $37.82 | |||
| Day High | $41.70 | P/E | N/A | |||
| Day Low | $40.96 | EPS | $0.00 | |||
| Volume | 5,989,597 | |||||



